Ildong Pharmaceutical
Manufacturing · South Korea · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
2 Baumoe-ro 27-gil, Seoul, Seoul, South ...Phone Number
+82 25263114Website
www.ildong.comRevenue
$436.2 MillionStock Symbol
249420Industry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Ildong Pharmaceutical
Ildong Pharmaceutical is a leading pharmaceutical company in South Korea. With 78 years of history, Ildong brand carries high reputation in local healthcare market for its high-quality service and diverse range of ETC & OTC products serving healthcare professionals and consumers. The company has envisioned ourselves to become an innovative R&D-based pharmaceutical company developing novel therapeutic options for diseases with high unmet needs. Ildong's R&D focus is therapeutic area such as oncology, immune-oncology, endocrinology, liver fibrosis, and neurology.Explore more
Ildong Pharmaceutical Org Chart
AS
Manager
YK
Manager
YH
Manager
KP
Manager
JK
제조부서책임자 / 과장
JL
과장
NA
Manager
HL
Manager
HK
차장
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ildong Pharmaceutical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Ildong Pharmaceutical, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Ildong Pharmaceutical launches new products
Congratulate Masked Content for being promoted to Masked Content at Ildong Pharmaceutical
Check out if Ildong Pharmaceutical is spiking on competitors!
Funding: Get notified immidiatlly once Ildong Pharmaceutical has new funding data
Earning: See what the market has to say on Ildong Pharmaceutical recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Ildong Pharmaceutical has recently received funding, and reach out quickly before it becomes old news!
Click to see if Ildong Pharmaceutical had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Ildong Pharmaceutical as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Ildong Pharmaceutical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ildong Pharmaceutical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ildong Pharmaceutical.
Ildong Pharmaceutical Tech Stack
A closer look at the technologies used by Ildong Pharmaceutical
Ildong Pharmaceutical News & Media
Ildong Pharmaceutical sells D&D Pharmatech stake, posts 50% gain in one month
Ildong Pharmaceutical sells D&D Pharmatech stake, nets 50% gain in one month Ildong Pharmaceutical to sell 0.49% stake in D&D Pharmatech after one-month 50% paper gainYunovia Announces IND Approval by the MFDS to Initiate Phase 1 MAD Study for the Small Molecule GLP-1 Agonist
SEOUL, South Korea, Aug. 28, 2024 /PRNewswire/ -- Yunovia, a drug R&D subsidiary of Ildong Pharmaceutical Group, announced on the 26th that the Ministry of Food and Drug Safety (MFDS) of Korea has cleared the IND application of Phase 1 Multiple Ascending Dose (MAD) study for ID110521156, an orally available small molecule GLP-1 agonist being developed for obesity and diabetes following the successful completion of the Phase 1 Single Ascending Dose (SAD) study. Phase 1Ildong Pharma to spin off R&D subsidiary in Nov - KED Global
South Korea’s Ildong Pharmaceutical Co. will spin off its research and development (R&D) unit into the subsidiary Yunovia from Nov. 1. The new eTwist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology
SOUTH SAN FRANCISCO, Calif. & SEOUL, South Korea--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Ildong Pharmaceutical, today announced an agreement under which Ildong will license a suite of Twist VHH antibody libraries to use to discover and develop antibodies for applications in immuno-oncology. “This collaboration with Twist moves us closer to our vision
Read more news
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding Ildong Pharmaceutical
Sign Up For FreeTo access detailed company insights
Ildong Pharmaceutical is a leading pharmaceutical company in South Korea. With 78 years of history, Ildong brand carries high reputation in local healthcare market for its high-quality service and diverse range of ETC & OTC products serving healthcare professionals and consumers. The company has envisioned ourselves to become an innovative R&D-base... Read More
